Rural hospitals’ revenue would be squeezed if Medicaid expansion rolled back

Almost 700 rural hospitals have been deemed at risk of closing thanks to financial struggles. As Kaiser Health News reports, the loss of expanded Medicaid could push those facilities over the edge.

“All these rural hospitals are operating on thin margins. The removal of any income source or coverage, or expansion of bad debt, is going to create significant financial hardship,” said Alan Morgan, CEO of the National Rural Health Association.

Kaiser visited one such hospital, the 64-bed Highlands Hospital in Connellsville, Pennsylvania, which has a population of just over 7,600. Close to one-third of the county’s population has Medicaid after eligibility was expanded, but closure is still a “daily concern,” according to the hospital’s CFO, John Ardusky.

“It seems like you’re taking two steps forward, three steps back,” Ardusky said. “It’s not like I can look to five years out—because I have to worry about tomorrow. I can’t worry about next year.”

Read the full article below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup